Recent Event Highlights: Who Are The Real Terrorists? - Part 2, Who Are The Real Terrorists? - Part 1, Bill Gates Foundation $10 billion for vaccines - Helping Children or Big Pharma _.avi, Gates Foundation $10 billion for vaccines - Helping Children or Big Pharma ?, Davos Annual Meeting 2010 - Meeting the Millennium Development Goals, Leprosy in India, and 44 more...
Created by dipity on Mar 24, 2009
Last updated: 01/10/11 at 06:32 AM
Novartis India has no followers yet. Be the first one to follow.
Terrorist names List: Queen Beatrix of the Netherlands Queen Sofía of Spain Prins Filip Belgian Prince Étienne Davignon, Belgium Josef Ackermann, Germany Keith B. Alexander, Director of the NSA, USA Roger Altman, USA Takis Arapoglou, National Bank of Greece, Greece Ali Babacan, Turkey Balsemão, Francisco Pinto, Portugal Nicolas Baverez, France Franco Bernabè, Italy Xavier Bertrand. France Bildt, Carl, Sweden Jan Björklund, Minister for Education, Sweden Christoph Blocher, Switzerland Alexandre Bompard, France, (europe 1 ( french radio )) Ana Botín (President of Santander Bank Group Emilio Botín´s daughter), Spain. Henri de Castries, AXA, France Juan Luis Cebrián, (PRISA Group of Media, CEO), Spain. W. Edmund Clark, TD Bank Financial Group, Canada Kenneth Clark, ΤD Βank Financial Group, Great Britain Luc Coene, National Bank of Belgium, Belgium Richard Dearlove, ex head MI6, Great Britain Mario Draghi, Βanca d΄Ιtalia, Italy Eldrup, Anders, Denmark Elkann, John, Fiat SPA, Italy Enders Thomas, CEO Airbus, Germany José (Manuel) Entrecanales (Acciona Group, Construction and infrastructures), Spain. Isidro Fainé Casas (President of Caixa "Bank" and SEAT Adviser), Spain. Niall Ferguson, Harvard Business School, USA Timothy Geithner, USA, Secretary of the Treasury] Dermot Gleeson, Ireland Donald E. Graham Washington Ρost Company Halberstadt, Victor, Professor of Economics, Leiden University, Netherlands Ernst Hirsch Ballin, Netherlands Richard Holbrooke, USA Jaap de Hoop Scheffer ...
Terrorist names List: Queen Beatrix of the Netherlands Queen Sofía of Spain Prins Filip Belgian Prince Étienne Davignon, Belgium Josef Ackermann, Germany Keith B. Alexander, Director of the NSA, USA Roger Altman, USA Takis Arapoglou, National Bank of Greece, Greece Ali Babacan, Turkey Balsemão, Francisco Pinto, Portugal Nicolas Baverez, France Franco Bernabè, Italy Xavier Bertrand. France Bildt, Carl, Sweden Jan Björklund, Minister for Education, Sweden Christoph Blocher, Switzerland Alexandre Bompard, France, (europe 1 ( french radio )) Ana Botín (President of Santander Bank Group Emilio Botín´s daughter), Spain. Henri de Castries, AXA, France Juan Luis Cebrián, (PRISA Group of Media, CEO), Spain. W. Edmund Clark, TD Bank Financial Group, Canada Kenneth Clark, ΤD Βank Financial Group, Great Britain Luc Coene, National Bank of Belgium, Belgium Richard Dearlove, ex head MI6, Great Britain Mario Draghi, Βanca d΄Ιtalia, Italy Eldrup, Anders, Denmark Elkann, John, Fiat SPA, Italy Enders Thomas, CEO Airbus, Germany José (Manuel) Entrecanales (Acciona Group, Construction and infrastructures), Spain. Isidro Fainé Casas (President of Caixa "Bank" and SEAT Adviser), Spain. Niall Ferguson, Harvard Business School, USA Timothy Geithner, USA, Secretary of the Treasury] Dermot Gleeson, Ireland Donald E. Graham Washington Ρost Company Halberstadt, Victor, Professor of Economics, Leiden University, Netherlands Ernst Hirsch Ballin, Netherlands Richard Holbrooke, USA Jaap de Hoop Scheffer ...
Self Bank es un banco on line . Te regalamos 1.000 euros en comisiones de bolsa si aún no eres cliente. Visítanos en www.selfbank.es. Comenzamos el martes con nuevos temores de sobrecalentamiento de otra economía emergente, India, que ha elevado por segunda vez consecutiva en un mes tipos con la intención de poner freno a la inflación. El sentimiento negativo que pesó ayer sobre las bolsas en el sector bancario y de aerolíneas parece ir disipándose, de forma que los mercados europeos han abierto con subidas. La noticia que ha saltado al mercado sobre la división de los miembros de la SEC a la hora de interponer la demanda contra Goldman está mejorando el optimismo en el sector, que encabeza las subidas del Eurostoxx50. Pero sin duda el valor protagonista es Daimler, que se desmarca con una revalorización superior al 6% gracias a la mejora de previsiones en dos de sus divisiones. También esperamos buen comportamiento por parte de Novartis, tras una publicación de resultados por encima de lo estimado. Optimismo que no mantenemos hoy con respecto al sector tecnológico, que podría verse penalizado como consecuencia de la disminución de los contratos de servicios reflejada ayer por IBM. Nuevas declaraciones preocupantes con respecto a Grecia después de que el Presidente de su Banco Central señalase que podría necesitar más de los 30.000 Mn€ ofrecidos por los gobiernos de la UE.
Video from: TruTHTVSpokaneWA 30 gennaio 2010 Info from: TruTHTVSpokaneWA Berna Biotech TT, MR (measles, rubella combination) Berna Biotech Korea Corp. Hepatitis B (recombinant), DTP-Hep B-Hib (fully liquid pentavalent) (Quinvaxem) Bio Farma, Indonesia DT, DTP, DTP-Hep B... Berna Biotech TT, MR (measles, rubella combination) Berna Biotech Korea Corp. Hepatitis B (recombinant), DTP-Hep B-Hib (fully liquid pentavalent) (Quinvaxem) Bio Farma, Indonesia DT, DTP, DTP-Hep B, Hepatitis B filled in Uniject ,OPV, TT, TT filled in Uniject, Measles, Measles (20 doses) Biomanguinhos, Brazil yellow fever (5, 10 and 50 doses) , polysaccharide meningococcal A and C vaccine (10 doses in glass vials) Center for Genetic Engineering and Biotechnology, Cuba Hepatitis B(recombinant) Novartis Vaccines and Diagnostics GmbH & Co. KG, Germany (formerly Chiron Behring) DTP, Rabies Novartis Vaccines and Diagnostics Srl, India (formerly Chiron Behring) Rabies Novartis Vaccines and Diagnostics Srl, Italy (formerly Chiron Vaccines) OPV, Hib, DTP-Hib CSL, Australia DTP, TT GlaxoSmithKline, Belgium Hepatitis B (recombinant), Hib, OPV (produced in MRC-5), meningococcal A + C, meningococcal ACW 135; DTP-Hep B (Tritanrix) , DTP-Hep B to be combined with Hib (pentavalent) (Tritanrix-Hib) , DTP-Hep B (Zilbrix) , DTP-Hep B + Hib (Zilbrix-Hib), measles, MMR, Rotavirus (Rotarix) Haffkine Bio Pharmaceutical Corporation Ltd, India OPV (from bulk supplied by Biofarma, Indonesia) Institut Pasteur Dakar, Senegal ...
Berna Biotech TT, MR (measles, rubella combination) Berna Biotech Korea Corp. Hepatitis B (recombinant), DTP-Hep B-Hib (fully liquid pentavalent) (Quinvaxem) Bio Farma, Indonesia DT, DTP, DTP-Hep B, Hepatitis B filled in Uniject ,OPV, TT, TT filled in Uniject, Measles, Measles (20 doses) Biomanguinhos, Brazil yellow fever (5, 10 and 50 doses) , polysaccharide meningococcal A and C vaccine (10 doses in glass vials) Center for Genetic Engineering and Biotechnology, Cuba Hepatitis B(recombinant) Novartis Vaccines and Diagnostics GmbH & Co. KG, Germany (formerly Chiron Behring) DTP, Rabies Novartis Vaccines and Diagnostics Srl, India (formerly Chiron Behring) Rabies Novartis Vaccines and Diagnostics Srl, Italy (formerly Chiron Vaccines) OPV, Hib, DTP-Hib CSL, Australia DTP, TT GlaxoSmithKline, Belgium Hepatitis B (recombinant), Hib, OPV (produced in MRC-5), meningococcal A + C, meningococcal ACW 135; DTP-Hep B (Tritanrix) , DTP-Hep B to be combined with Hib (pentavalent) (Tritanrix-Hib) , DTP-Hep B (Zilbrix) , DTP-Hep B + Hib (Zilbrix-Hib), measles, MMR, Rotavirus (Rotarix) Haffkine Bio Pharmaceutical Corporation Ltd, India OPV (from bulk supplied by Biofarma, Indonesia) Institut Pasteur Dakar, Senegal yellow fever Japan BCG BCG LG Life Sciences Ltd. , Korea Hepatitis B (recombinant) Merck and Co. Inc, USA Hepatitis B (recombinant), Hib BB-NCIPD Ltd., Bulgaria, Intervax, Canada BCG, TT, DT, dT Panacea Biotec, India DTP Biofarma - Hib Novartis (1 dose) (EASYFOUR), DTP Biofarma ...
www.weforum.org 29.01.2010 The combination of food and financial crises trapped an estimated 50 to 90 million people in extreme poverty in 2009. How can the Millennium Development Goals for 2015 be met in the wake of the economic crisis? Vikram K. Akula, Founder and Chairperson, SKS Microfinance, India; Young Global Leader; Global Agenda Council on Poverty & Development Finance Helen E. Clark, Administrator, United Nations Development Programme (UNDP), New York William H. Gates III, Co-Chair, Bill & Melinda Gates Foundation, USA Michel Kazatchkine, Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), Geneva; Global Agenda Council on a Healthy Next Generation Jeffrey D. Sachs, Director, The Earth Institute, Columbia University and Special Adviser to the UN Secretary-General on the Millennium Development Goals, USA Morgan Tsvangirai, Prime Minister of Zimbabwe Moderated by Lord Malloch-Brown, Senior Adviser, Global Redesign Initiative, World Economic Forum
Leprosy is a very ancient disease. Millions of people have been cured over the past 20 years, but leprosy still exists today. The stigma related to leprosy often forces patients to live separate from their families. This video shows how the stigma can be reduced through early treatment and by empowering patients. With this project in India, the Novartis Foundation for Sustainable Development helps patients reintegrate into society and lead a normal life.
Today Swiss pharmaceuticals maker Novartis AG announced it will buy US biopharmaceutical company Corthera Inc. for $120 million, giving it the right to develop a new drug against heart failure. India has emerged the leader in small cars, overtaking Japan, as the global map of the auto industry is redrawn. Automakers are pouring hundreds of millions of dollars into the country, hoping to capture a piece of the growing market for tiny, inexpensive passenger vehicles, quietly transforming India into an export hub for small car manufacturing. Today Wells Fargo, the fourth-largest US bank, said it repaid the $25 billion government bailout it received during the financial crisis, after last week selling $12.25 billion in stock. It also has paid dividends of $1.4 billion on the government's investment since it took the bailout. US stocks hovered near a flatline today as new-home sales dropped to their lowest level in seven months, but gains in commodities drove energy and materials companies higher... In the nights before Christmas, some US retailers are opening their doors round the clock to wring out every last possible holiday sale. Now if they can find a few consumers with money burning the midnight oil hunting for bargains Escondido based Stone Brewing Co., the creators of Arrogant Bastard Ale, is seeking partners to build a brewery in Europe. Brewing in Europe would mean that Stone beers sold in say, London or Rome, would taste fresh. Economic and environmental costs of ...
eedition.toronto.24hrs.ca
Here I am singing Kabhi Kabhi Aditi song from the movie Jane Tu Ya Jane Na at NICE India Day Cultural event on 16th Oct 2009 in Novartis Campus, East Hanover, NJ, US. This song was originally sung by Rashid Ali in this movie in year Jul, 2008. Listen to this and let me know your feedback and comments.
KSU activists protest outside Kochi's Novartis India Limited office against the whooping price of the cancer drug Sandostatin.
Post-BulletinMalcolm Berko: Stimulus dwarfed by mountain of debtPost-Bulletin, MN... he turns on a laptop computer made in India, puts his feet up on a desk made in Mexico and uses a cell phone made in Finland. He turns on his office television made in Japan and calls his broker to buy 200 shares of Novartis located in Switzerland ...
http://www.postbulletin.com/newsmanager/templates/localnews_story.asp?z=7&a=391190
AME InfoHarvard Medical School Dubai Center launch Diabetes program with ...AME Info, United Arab Emirates... Novartis, AstraZeneca, Smith & Nephew, Fresenius Medical Care, Novo Nordisk, among others. The second phase will feature a dedicated wellness cluster comprised of Wellness centers, Nutrition centers, Resorts, Spas, and Sports Medicine facilities. ...
http://www.ameinfo.com/189680.html
ReutersRivals benefit from generic drugmaker setbacksReutersA) and Sandoz, the generic drug unit of Novartis (NOVN.VX), have all been cited for problems by the US Food and Drug Administration. Some have been particularly severe: KV was forced to stop manufacturing and selling products at all its facilities ...
http://www.reuters.com/article/ousiv/idUSTRE52L0TS20090322
Excerpt
...has poured billions of dollars into building up its pharmaceutical industry as it loses electronics jobs to China and India. The government a few years ago built a biomedical hub known as "Biopolis"--a number of interconnected futuristic office towers where...
Source Info
Wall Street Journal
http://online.wsj.com/article/SB123757905697398509.html#mod=WSJ_topics_obama
เดอะ เนชั่นInterview : Mechai Viravaidyaเดอะ เนชั่น, ThailandHere, starting with Bangkok Glass, we have secured assistance from many companies such as Swedish Motors and Novartis, which is implementing a similar project in every country in which it operates. We have also struck an agreement with the Stock ...
http://www.nationmultimedia.com/2009/03/16/national/national_30097955.php
SYS-CON MediaS*BIO Receives BioSpectrum Editor's Choice, Emerging BioScience ...SYS-CON Media, NJS*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. ...
http://ca.sys-con.com/node/866128
Business Wire (press release)Saba Ranked Among NASSCOM’s 15 ‘Exciting Emerging Companies To ...Business Wire (press release), CA“We are honored to be recognized as one of the top exciting, emerging companies to work for by a leading industry trade body like NASSCOM,” said Gaurav Mehra, managing director for Saba India. “Our core values define who we are and what we believe ...
http://www.businesswire.com/news/google/20090305005344/en
The Money TimesPfizer Eyes Generic GrowthThe Money Times, IndiaBut it avoids setting up a massive research and development operation that would be required to compete well against larger players like Novartis (NYSE: NVS) and Teva Pharmaceutical (Nasdaq: TEVA). Pfizer's stock has taken a beating since the company ...
http://www.themoneytimes.com/articles/20090304/pfizer_eyes_generic_growth-id-1052667.html
Moneycontrol.comPfizer expands agreement with Aurobindo to 44 drugs from 5Moneycontrol.com, IndiaSandoz of Novartis is the only company that has taken a full fledged dip into the world of generics. Pfizer is also taking this unconventional method, and so far as Aurobindo is concerned, the biggest thing that will happen is that eight of its US- ...
http://www.moneycontrol.com/india/news/business/pfizer-expands-agreementaurobindo-to-44-drugs5/387717
Graduation Ceremony for the post-MBA Program Class of 2008 and 2009, held in September of 2008, and February of 2009 at the Northwestern University Kellogg School of Management in Evanston, Illinois at the Allen Center for Executive Education. Graduates include: Luciano Arranz, Antonio Arranz, Michael S. Bogovich,Mike Bogovich, Charles Campbell, Chuck Campbell, Rodrigo Corces, Marcelo DeSantis, Andre P. Ezers, Joseph Jerome Francia, Ian Henderson,Kristen Hoefer,Vicki S. Holschuh,Jeffrey G ...
Every Indian kid remembers the doggy shaped jar of daily supplement Calcium Sandoz, from Novartis. ...
Made by students from my Economics of HIV class at Williams College: Melinda Salaman, Maia Dickinson and Simon Kloeckner ...
http://www.njbajafresh.com Pretty Music and Delicious Food that itself cannot be lost. New Jersey Baja Fresh is promoting Delivery and To Go for Party and Meetings of Business, so much in the Office as for the Home. Google and YouTube have many links for belly dance, but Baja Fresh is the only in fresh fast food. ...
Interview with Fernando Pascual, Pharmacist, MSF Campaign for Access to Essential Medicines, on the case that pharmaceutical company Novartis is bringing against the Indian Government and the effect this will have on HIV patients. ...
Excerpt
...raised certain corporate governance issues, especially those relating to inter-group transactions by the pharma company. Novartis India has inter-corporate deposits outstanding from its group companies to the tune of Rs 340 crore — as of March 2008 — which...
Source Info
Economic Times
http://economictimes.indiatimes.com/Personal_Finance/Mutual_Funds/MF_News/Reliance_MF_doubts_Novartis_inter-group_deals/rssarticleshow/3362524.cms
Excerpt
...marine sources, rain-forests, fungi and micro-organisms for the natural ingredients that they make to protect themselves, said Novartis India’s outgoing Chairman, Dr Peter Jager, of the project that is a pursuit of the parent company. With its vast bio-resources,...
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2008/07/17/stories/2008071751450200.htm
! EDU-TAINMENT ! HIV / Aids in Tanzania, Africa. Traditional Healers vs. expensive western pharmaceuticals. Copyright laws on drugs. Novartis vs. drug factories in India. www.maketradefair.com, Oxfam.com. Language: Swahili, English (Subtitles) ## FOGO Productions ## ...
! EDU-TAINMENT ! HIV / Aids in Tanzania, Africa. Traditional Healers vs. expensive Western pharmaceuticals. Copyright laws on drugs. Novartis vs. drug factories in India. www.maketradefair.com, Oxfam.com. Language: Swahili, English (Subtitels) ## FOGO Productions ## ...
Excerpt
... Part 6: Payback: Novartis To Slash Investment In India The Novartis CEO Vasella says he will switch hundreds of millions of dollars in planned investments from India to other locations, primarily, China, in response to an Indian court ruling that he says...
Source Info
UK Indymedia Newswire
http://www.indymedia.org.uk/en/2008/04/395947.html
http://www.stefanosalvi.it/ L'organizzazione Mondiale della Sanità ha riconosciuto lecita la produzione di farmaci generici ANTI-AIDS in India e non fondato il ricorso della multinazionale Novartis. Questa è una svolta epocale, grazie anche al contributo e al movimento che si è creato dal basso in tutto il mondo affinché questo fosse reso possibile e venisse fermato lo strapotere della case farmaceutiche. ...
http://www.stefanosalvi.it/ Stefano Salvi torna a Medici senza Frontiere per riaffrontare il problema dei farmaci ANTI-AIDS prodotti in India ad un costo decine di volte inferiore rispetto a quanto venduto dalla casa farmaceutica Novartis. La nota multinazionale aveva cercato di impedire che in India si producessero farmaci a cosi' basso costo su brevetto Novartis. Pare che la cosa si sia conclusa e la Novartis, sotto il peso di oltre 400.000 firme, abbia dichiarato di aver ritirato la ...
2008年1月30日から2月4日まで、インド・ハイデラバードで開催された第17回国際ハンセン病学会の様子。 世界24カ国のハンセン病回復者団体代表や、NGO、WHO、保健省関係者ら1200名以上が集まった。 関連する「日本財団ブログ・マガジン」の記事http://blog.canpan.info/koho/archive/349 The 17th International Leprosy Conference Hyderebad, India, 30th Jan. - 4th Feb. ...
Excerpt
...since late 2003, when it was the first pharmaceutical company to be granted an Exclusive Marketing Rights in the country. Novartis then tried to legally prevent companies like Natco, Cipla and Ranbaxy from selling generic or similar versions of Glivec in India....
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2007/11/14/stories/2007111452110300.htm
Excerpt
...- these lawyers had star power, but never tried a patent case before. The upshot: Lawyers with experience in India say that Novartis chose a losing litigation strategy and stuck with it. “The law firm that started the case for Novartis made fundamental errors,...
Source Info
Pharmalot
http://feeds.feedburner.com/~r/Pharmalot/~3/164672835/
Excerpt
...to China, though it stands to reason that at least part of the money may eventually find a home there. Novartis portrayed its India and China commitments as part of a move to build up its presence in Asia. Before the November announcement, Novartis already...
Source Info
ETF Investor
http://seekingalpha.com/article/45694-will-novartis-move-funds-intended-for-india-to-china?source=feed
Closing Plenary: What We Should Do in 2005 This year's Annual Meeting emphasized 12 Tough Issues: China, Climate Change, Equitable Globalization, Europe, Global Economy, Global Governance, Islam, Middle East, Poverty, US Leadership, Weapons of Mass Destruction and World Trade. This session will focus on the best initiatives proposed to tackle the top six issues prioritized in the opening plenary. 1) Which issues not identified in the Opening Plenary should have priority for the global agenda ...
Excerpt
...including Russia and China. Speaking of the Madras High Court's ruling, Ranjit Shahani, vice chairman and managing director of Novartis India, said in a statement Monday, We disagree with this ruling; however we likely will not appeal to the Supreme Court....
Source Info
Forbes
http://www.forbes.com/markets/2007/08/07/novartis-glivec-generics-markets-equity-cx_rd_0807markets02.html?partner=rss
Excerpt
...long-term negative consequences for research and development into better medicines for patients in India and abroad'. Novartis says the Indian patent system stifles innovation, such as making a drug more heat-resistant or able to be swallowed rather than injected. Critics...
Source Info
Malaysia Sun
http://story.malaysiasun.com/index.php/ct/9/cid/b8de8e630faf3631/id/9601898/
Excerpt
...with this ruling, however we likely will not appeal to the Supreme Court," said Ranjit Shahani, the managing director of Novartis India Limited. "It is clear there are inadequacies in Indian patent law that will have negative consequences for patients and...
Source Info
Boston Globe
http://www.boston.com/news/world/europe/articles/2007/08/06/india_rejects_novartis_drug_patent_case?rss_id=Boston.com+%2F+News
Excerpt
...written judgment, he added. Novartis had objected to Mr Chandrasekaran’s appointment to the IPAB, as he was the head of the Indian Patent Office when it rejected Novartis’s patent application for its cancer drug, Glivec, in January 2006. In its order, issued...
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2007/07/21/stories/2007072152220300.htm
Excerpt
...the production of cheap generic drugs," said Menghaney. Last week, the Madras High Court reserved its verdict on the Novartis challenge against the Indian patent system. It also ordered that another challenge by Novartis to a January decision that rejected...
Source Info
Reuters Alert Net
http://www.alertnet.org/thenews/newsdesk/DEL295545.htm
Novartis firmly believes that patents save lives by stimulating research, leading to innovative medicines. Ranjit Shahani, Vice-Chairman and Managing Director of Novartis India Limited, explains the importance of GIPAP to India, the significance of Glivec to cancer patients, and the value of intellectual property rights to medical innovation. For more information about our perspective on access to medicines and patent protection in India, please visit our India Glivec patent case information ...
Novartis offers help and hope to CML patients in India through its patient assistance program - offering life-saving medicines absolutely free. Viji Venkatash, head of MaxStation India and MaxStation Coordinator Asia Pacific Region, offers insight into the key role that GIPAP, the Max Foundation and Novartis play in the lives of CML patients in India. For more information about our perspective on access to medicines and patent protection in India, please visit our India Glivec patent case ...
Excerpt
...have guidelines to follow: Novartis Novartis case: Conversion of writ petitions referred to CJ Novartis' charges against Indian patent law refuted Stories in this Section Most AAI employees reject Delhi airport co's incentive offer Outlook for rogue westerly...
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2007/03/07/stories/2007030705150200.htm
Novartis, a global pharmaceutical giant, is challenging India's patent law. India supplies half of all AIDS medications used in poor countries. If Novartis wins its court case, access to AIDS treatment could be shut off for hundreds of thousands of people. Their lives hang in the balance. On February 14, 2007, AIDS activists demonstrated outside Novartis offices in Cambridge, Massachusetts, during a blizzard. Want to remix this video? See the press pack at http://wakeupsilver.blogspot.com ...
Médicos Sin Fronteras e Intermón Oxfam exigimos a la farmacéutica Novartis que no obstaculice el acceso de medicamentos básicos a los países más pobres. ...
Milhões de pessoas pobres nos países em desenvolvimento estão morrendo porque não podem pagar pelos medicamentos que tão desesperadamente precisam. Os países ricos, especialmente Estados Unidos, pressionam os países em desenvolvimento para que aceitem regras mais estritas sobre propriedade intelectual, que permitam às empresas farmacêuticas preservar seus monopólios. Isso reduz a competitividade dos medicamentos genéricos e mantém os preços muito altos. Em 2005, várias associações de vítimas ...
Excerpt
...its attempt to patent a new version of leukemia drug Gleevec, known in Europe and India as Glivec. If Novartis wins the civil suit, Indian firms would be banned from making generic versions of the drug. Activists fear this could set a precedent for other pharmaceutical...
Source Info
Boston Globe
http://www.boston.com/news/world/europe/articles/2007/01/29/protesters_in_india_slam_novartis?rss_id=Boston.com+%2F+News
Excerpt
...generic versions of the drug, which is known in Europe and India as Glivec. A court in Chennai will hear the case on Monday. Novartis claims India's laws are unfair because they currently allow Indian firms to manufacture far cheaper imitations of products...
Source Info
Al Jazeera
http://english.aljazeera.net/NR/exeres/B6C5C2C5-C8A8-4ED2-8BBB-100265C6B9EB.htm
Update Sources